SQI Diagnostics Inc.
SQDH.V
TSX
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -95.76% | 452.56% | 711.72% | 302.12% | 1,667.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -95.76% | 452.56% | 711.72% | 302.12% | 1,667.84% |
| Cost of Revenue | -78.97% | 4,615.00% | 6,333.33% | 1,639.66% | 4,657.24% |
| Gross Profit | -110.95% | 63.55% | -368.63% | 68.84% | 1,026.73% |
| SG&A Expenses | -60.12% | -28.36% | -40.89% | 234.48% | 56.95% |
| Depreciation & Amortization | -- | 94.96% | 4,510.98% | 3,450.96% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -75.14% | -15.85% | 91.93% | 535.19% | 92.79% |
| Operating Income | 26.12% | 24.20% | -56.12% | -666.37% | 38.19% |
| Income Before Tax | -27.71% | 16.19% | -192.59% | -573.87% | 27.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.71% | 16.19% | -192.59% | -573.87% | 27.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.71% | 16.19% | -192.59% | -573.87% | 27.39% |
| EBIT | 26.12% | 24.20% | -56.12% | -666.37% | 38.19% |
| EBITDA | 15.51% | 25.81% | 1.06% | -564.10% | 50.34% |
| EPS Basic | -25.00% | 20.83% | -168.42% | -513.33% | 38.10% |
| Normalized Basic EPS | 9.09% | 2.22% | -97.30% | -470.00% | 43.10% |
| EPS Diluted | -25.00% | 20.83% | -168.42% | -513.33% | 38.10% |
| Normalized Diluted EPS | 9.09% | 2.22% | -97.30% | -470.00% | 43.10% |
| Average Basic Shares Outstanding | 3.75% | 4.58% | 8.51% | 13.60% | 16.79% |
| Average Diluted Shares Outstanding | 3.75% | 4.58% | 8.51% | 13.60% | 16.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
